Wided Najahi-Missaoui

Title: Wided Najahi-Missaoui: Innovator in Lipid-Based Drug Delivery Systems

Introduction

Wided Najahi-Missaoui is a prominent inventor based in Athens, GA (US). She has made significant contributions to the field of drug delivery systems, particularly through her innovative work on lipid-based vehicles. With a total of 2 patents, her research focuses on enhancing the efficacy of cancer treatments.

Latest Patents

Najahi-Missaoui's latest patents include the development of IPA-3-loaded liposomes and methods of use thereof. These lipid-based delivery vehicles are designed to improve the administration of p21 activated kinase (PAK) inhibitors. The nanoparticulate compositions typically include a PAK inhibitor and a lipid-based delivery vehicle, which is preferably a sterically-stabilized liposome. The formulation includes phospholipids and optionally a sterol, with specific embodiments featuring DSPC, DSPE-PEG2000, and cholesterol in a ratio of 9:1:5. The methods of use for these compositions aim to treat various cancers, particularly prostate and breast cancer, by administering the composition to patients in need.

Career Highlights

Wided Najahi-Missaoui is affiliated with the University of Georgia Research Foundation Inc., where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer treatment methodologies.

Collaborations

Some of her notable coworkers include Somanath Rammohan Shenoy and Brian Cummings, who contribute to her research initiatives.

Conclusion

Wided Najahi-Missaoui's innovative work in lipid-based drug delivery systems represents a significant advancement in cancer treatment. Her contributions through her patents and research at the University of Georgia Research Foundation Inc. highlight her role as a leading inventor in this critical field.